Abbott (NYSE:ABT) and Cardiovascular Systems, Inc. (CSI), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
On December 31, 2023, Chief Financial Officer Jerry Wenzel Retired From Employment With SOBR Safe, Inc.; Company Appointed Christopher Whitaker As The Chief Financial Officer Of The Company, Effective January 1, 2024
– SEC Filing On December 31, 2023, Jerry Wenzel retired from employment with SOBR Safe, Inc. (the "Company"). Mr. Wenzel has served as Chief Financial Officer of the Company since January 2022. In connection
